Citi Starts Mirum Pharamceuticals (MIRM) at Buy

September 1, 2022 2:44 AM EDT
Get Alerts MIRM Hot Sheet
Price: $98.97 +0.75%

Rating Summary:
    16 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE

Citi analyst David Lebowitz initiates coverage on Mirum Pharamceuticals (NASDAQ: MIRM) with a Buy rating and a price target of $38.00.


For an analyst ratings summary and ratings history on Mirum Pharamceuticals click here. For more ratings news on Mirum Pharamceuticals click here.


Shares of Mirum Pharamceuticals closed at $24.98 yesterday.


You May Also Be Interested In





Related Categories

New Coverage